Engineering Diffusion Barriers in the Plasma Membrane
Engineering Diffusion Barriers in the Plasma Membrane
Disciplines
Biology (100%)
Keywords
-
Plasma Membrane,
Diffusion Barrier,
Serotonin Transporter,
Single Molecule Microscopy
Each cell is enveloped by a plasma membrane. This membrane fulfills a large number of tasks that are essential for the cell, including protection against the undesired influx of dangerous substances, but also the specific uptake of desired substances. A lipid bilayer represents the central structure of most plasma membranes. It is an extremely thin layer that is impenetrable for many substances, but which is still surprisingly dynamic and fluid. Hundreds of different types of proteins are embedded in this lipid layer, for example those proteins that transport certain substances from the outside to the inside in a highly selective manner. In our project we are trying to better understand one such transporter protein, namely the transporter for serotonin. Serotonin is a neurotransmitter, i.e. a messenger substance that is important for the transmission of signals between nerve cells. After the serotonin has been released into the vicinity of the nerve cell, a signal is triggered on nearby nerve cells. To end the signaling process, it is therefore necessary to remove serotonin from the vicinity of the nerve cell and make it available for further releases. In order to operate this uptake process efficiently, it seems important not to distribute the serotonin transporter evenly across the nerve cells, but to place it in those places where neurotransmitter uptake makes sense. In our project we therefore address two questions: What is the spatial arrangement of the serotonin transporter in the plasma membrane of nerve cells? To answer this question, we will use novel microscopy methods that make it possible to determine the distribution of the protein by means of single-molecule localization far below the classic optical resolution limit. Does the size of the protein play a role in the spatial arrangement? This question is based on a result from our joint preliminary work, which showed that the serotonin transporter is usually a structure made up of several proteins and moves as a so-called serotonin transporter oligomer in the plasma membrane. The mobility changes depending on the size of this oligomer, so that large protein complexes move more slowly than small ones. This difference is massively amplified as soon as immobile obstacles are built into the plasma membrane. Our assumption is now that nerve cells build immobile obstacles into the plasma membrane at certain points in order to virtually freeze the mobility of the transporter there. To test this, we will establish a semi-synthetic model system that will allow us to specifically build immobile obstacles in the plasma membrane and determine the effect on the movement of the serotonin transporter.
Transporter proteins are a class of proteins that facilitate the movement of an ion and/or molecule across the cell membrane. There are several different subclasses of transporters. Neurotransmitter transporters for monoamines, including serotonin, belong to the solute carrier 6 transporter family, which uses the electrochemical gradient of sodium for the transport of the monoamine. These transporters are primarily located perisynaptically in the pre-synaptic neuron. In this project we specifically studied the behavior of the serotonin transporter. This protein regulates the function of serotonin, which is colloquially known as the hormone of happiness. The serotonin transporter serves a crucial function within our nervous system: it is responsible for the reuptake of serotonin and thereby the termination of its action. Dysregulation of the serotonin transporter has been linked to multiple mental disorders such as depression and obsessive-compulsive disorder. The serotonin transporter is also the target of many medically approved and recreational drugs. Despite its clinical significance little is known about the mechanisms governing serotonin transporter assembly and function. Understanding its underlying molecular behavior, including movement and organization, will potentially allow for developing better treatment approaches. So far, there were limited options to selectively visualize the transporter in microscopy. Most modes of labelling were not exclusive to the serotonin transporter or posed other challenges with advanced microscopy techniques. Hence, we developed a version of the serotonin transporter with a short tag-sequence, which allows for specific labelling with custom fluorophores. This makes it ideal for a plethora of microscopy methods. We found that the developed transporter version retains its functionality and high-order oligomerization behavior. To assess the organization of the transporter in more detail, we performed superresolution experiments which allow for visualisation on a nanoscale. In particular, we were interested in the relation to the underlying cellular structures, which is known to arrange in a periodic pattern. We hypothesized that the serotonin transporter might be affected in its movement by those structures. It is a rather large molecule that has been shown to form high-order structures. First findings indicate that serotonin transporter arranges in a periodic fashion that may relate to the underlying cell structure.
- Harald H. Sitte, Medizinische Universität Wien , associated research partner
- Thomas Stockner, Medizinische Universität Wien , national collaboration partner
- Amy Hauck Newman, National Institute on Drug Abuse - NIH - USA
- Haley E. Melikian, University of Massachusetts Medical School - USA
Research Output
- 16 Citations
- 9 Publications
- 26 Scientific Awards
-
2025
Title Revealing the location and dynamics of a concealed binding site in the dopamine transporter. DOI 10.1038/s41467-025-59511-w Type Journal Article Author Sandtner W Journal Nature communications Pages 4197 -
2025
Title The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents. DOI 10.1038/s41380-025-03341-1 Type Journal Article Author Nadal-Gratacós N Journal Molecular psychiatry -
2025
Title Prolintane analogs as hybrid monoamine transporter ligands: structural determinants and species differences. DOI 10.1016/j.jbc.2025.110903 Type Journal Article Author Islam Mn Journal The Journal of biological chemistry Pages 110903 -
2024
Title Exploring FGFR3 Mutations in the Male Germline: Implications for Clonal Germline Expansions and Paternal Age-Related Dysplasias. DOI 10.1093/gbe/evae015 Type Journal Article Author Hartl I Journal Genome biology and evolution -
2024
Title PyrAtes: Modular Organic Salts with Large Stokes Shifts for Fluo-rescence Microscopy DOI 10.1002/anie.202318127 Type Journal Article Author Riomet M Journal Angewandte Chemie International Edition -
2023
Title Persistent binding at dopamine transporters determines sustained psychostimulant effects. DOI 10.1073/pnas.2114204120 Type Journal Article Author Niello M Journal Proceedings of the National Academy of Sciences of the United States of America -
2022
Title Editorial: Old and new psychoactive substances: Pharmacology and potential applications. DOI 10.3389/fpsyt.2022.1087005 Type Journal Article Author Luethi D Journal Frontiers in psychiatry Pages 1087005 -
2022
Title Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux DOI 10.1038/s42003-022-04210-1 Type Journal Article Author Luethi D Journal Communications Biology Pages 1259 Link Publication -
2023
Title The asymmetric plasma membrane-A composite material combining different functionalities?: Balancing Barrier Function and Fluidity for Effective Signaling. DOI 10.1002/bies.202300116 Type Journal Article Author Pabst G Journal BioEssays : news and reviews in molecular, cellular and developmental biology
-
2025
Title Symposium on near-field cell biology Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2025
Title Paul Scherrer Institute, Villigen, Switzerland, Korkhov group Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2025
Title Universität Heidelberg, Virtual seminar talk, Bunz group Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2025
Title Symposium 2025 - From Single Molecules to Cell Functions in Biomembranes Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2024
Title Annual Symposium of the German Pharmacological Society, Session "Novel therapeutic strategies for CNS disorders" Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2024
Title National Institutes of Health, Jacobsen Group, Bethesda, MD, USA Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title SFB 894 WORKSHOP - Cutting edge concepts in calcium signaling Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title corresponding member of the Austria Academy of Sciences Type Awarded honorary membership, or a fellowship, of a learned society Level of Recognition National (any country) -
2022
Title Second Symposium on Super-resolution and Advanced Fluorescence Microscopy Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title SLC13A5-International-Research-Roundtable, TESS Research Founda-tion, IST Austria, Klosterneuburg Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title GRC Membrane Transport Proteins, Castelldefels, Barcelona, Spain Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title Gordon Research Conference on Biointerface Science Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title NANOSCALE2022 Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2022
Title ITTS Symposium Copenhagen, Denmark: Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2021
Title Life Science PhD Meeting Innsbruck 202 Type Personally asked as a key note speaker to a conference Level of Recognition National (any country) -
2021
Title ImmunoBiophysics: From fundamental physics to understanding immune response Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2024
Title Biophysics Austria Conference 2024 Type Personally asked as a key note speaker to a conference Level of Recognition National (any country) -
2024
Title Florida Atlantic University, Virtual seminar talk (Seminar series, Center for Molecular Biology and Biotechnology) Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2024
Title UMass Chan Medical School, Worcester, MA, USA; Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2024
Title Johns Hopkins University, Baltimore, MD, USA Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2024
Title The Czech Biophysical Society 2nd meeting on experimental and medical biophysics Type Personally asked as a key note speaker to a conference Level of Recognition National (any country) -
2024
Title Exner-Lectures 2024, Palais Eschenbach, Vienna, Austria Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2023
Title ÖAW/CeMM Workshop on hot topics in modern medicine Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2023
Title Closing symposium of the RESOLUTE consortium: Unlocking Trans-porters for Drug Discovery, Vienna, Austria Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2023
Title EBSA Satellite Meeting Fluorescence fluctuation and single molecule spectroscopy Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2023
Title 780th WE-Heraeus Seminar on Developments in Advanced Microscopy and Spectroscopy Methods for Medicine Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International